Eric J Cotter1, Anirudh K Gowd2, Daniel D Bohl2, Alan Getgood3, Brian J Cole2, Rachel M Frank4. 1. Department of Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. 2. Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA. 3. Division of Orthopaedic Surgery, Fowler Kennedy Sport Medicine Clinic, Western University, London, Ontario, Canada. 4. Department of Orthopaedic Surgery, University of Colorado, Boulder, CO, USA.
Abstract
OBJECTIVE: To characterize rates and risk factors for adverse events following distal femoral osteotomy (DFO), high tibial osteotomy (HTO), and tibial tubercle osteotomy (TTO) procedures. DESIGN: Patients undergoing DFO, HTO, or TTO procedures during 2005 to 2016 were identified in the American College of Surgeons National Surgical Quality Improvement Program. Rates of adverse events were characterized for each procedure. Demographic, comorbidity, and procedural factors were tested for association with occurrence of any adverse events. RESULTS: A total of 1,083 patients were identified. Of these, 305 (28%) underwent DFO, 273 (25%) underwent HTO, and 505 (47%) underwent TTO. Mean ages for patients undergoing each procedure were the following: DFO, 51 ± 23 years; HTO, 40 ± 13 years; and TTO, 31 ± 11 years. The most common comorbidities for DFO were hypertension (34%) and smoking (17%); for HTO, hypertension (22%) and smoking (21%); and for TTO, smoking (20%) and hypertension (11%). Independent risk factors for occurrence of any adverse event were age ⩾45 years for DFO (odds ratio [OR] = 3.1, P < 0.001) and HTO (OR = 2.3, P = 0.029), and body mass index >30 for HTO (OR = 2.5, 95% confidence interval = 1.1-5.7, P = 0.031). When all osteotomy procedures were analyzed collectively, additional variables including diabetes mellitus (OR = 2.2, P = 0.017), chronic obstructive pulmonary disease (OR = 5.5, P = 0.003), and dependent functional status (OR = 3.0, P = 0.004) were associated with adverse events. CONCLUSIONS: The total rate of adverse events was not independently associated with the type of osteotomy procedure. In addition, patients with age >45, diabetes mellitus, chronic obstructive pulmonary disease, and dependent functional status have greater odds for adverse events and should be counseled and monitored accordingly.
OBJECTIVE: To characterize rates and risk factors for adverse events following distal femoral osteotomy (DFO), high tibial osteotomy (HTO), and tibial tubercle osteotomy (TTO) procedures. DESIGN:Patients undergoing DFO, HTO, or TTO procedures during 2005 to 2016 were identified in the American College of Surgeons National Surgical Quality Improvement Program. Rates of adverse events were characterized for each procedure. Demographic, comorbidity, and procedural factors were tested for association with occurrence of any adverse events. RESULTS: A total of 1,083 patients were identified. Of these, 305 (28%) underwent DFO, 273 (25%) underwent HTO, and 505 (47%) underwent TTO. Mean ages for patients undergoing each procedure were the following: DFO, 51 ± 23 years; HTO, 40 ± 13 years; and TTO, 31 ± 11 years. The most common comorbidities for DFO were hypertension (34%) and smoking (17%); for HTO, hypertension (22%) and smoking (21%); and for TTO, smoking (20%) and hypertension (11%). Independent risk factors for occurrence of any adverse event were age ⩾45 years for DFO (odds ratio [OR] = 3.1, P < 0.001) and HTO (OR = 2.3, P = 0.029), and body mass index >30 for HTO (OR = 2.5, 95% confidence interval = 1.1-5.7, P = 0.031). When all osteotomy procedures were analyzed collectively, additional variables including diabetes mellitus (OR = 2.2, P = 0.017), chronic obstructive pulmonary disease (OR = 5.5, P = 0.003), and dependent functional status (OR = 3.0, P = 0.004) were associated with adverse events. CONCLUSIONS: The total rate of adverse events was not independently associated with the type of osteotomy procedure. In addition, patients with age >45, diabetes mellitus, chronic obstructive pulmonary disease, and dependent functional status have greater odds for adverse events and should be counseled and monitored accordingly.
Authors: John M Wright; Heber C Crockett; Daniel P Slawski; Mike W Madsen; Russell E Windsor Journal: J Am Acad Orthop Surg Date: 2005 Jul-Aug Impact factor: 3.020
Authors: James D Wylie; Daniel L Jones; Melissa K Hartley; Ashley L Kapron; Aaron J Krych; Stephen K Aoki; Travis G Maak Journal: Arthroscopy Date: 2016-06-03 Impact factor: 4.772
Authors: Alex Schallberger; Matthias Jacobi; Peter Wahl; Gianluca Maestretti; Roland P Jakob Journal: Knee Surg Sports Traumatol Arthrosc Date: 2010-09-07 Impact factor: 4.342
Authors: Steven M Steinberg; Michael R Popa; Judith A Michalek; Matthew J Bethel; E Christopher Ellison Journal: Surgery Date: 2008-10 Impact factor: 3.982
Authors: Alexander Hoorntje; Suzanne Witjes; P Paul F M Kuijer; Koen L M Koenraadt; Rutger C I van Geenen; Joost G Daams; Alan Getgood; Gino M M J Kerkhoffs Journal: Sports Med Date: 2017-11 Impact factor: 11.136
Authors: Raghbir S Khakha; Hamid Rahmatullah Bin Abd Razak; Kristian Kley; Ronald van Heerwaarden; Adrian J Wilson Journal: J Clin Orthop Trauma Date: 2021-10-01